ArticleMedComm2024

The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancer.

Yalun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.